Simplex Trading’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,177
Closed -$319K 8443
2025
Q3
$286K Sell
51,177
-369
-0.7% -$1.59K ﹤0.01% 4517
2025
Q2
$170K Buy
+51,546
New +$148K ﹤0.01% 4678
2025
Q1
Sell
-16,353
Closed -$49.5K 8454
2024
Q4
$58K Buy
16,353
+3,813
+30% +$17.6K ﹤0.01% 5718
2024
Q3
$62K Buy
+12,540
New +$48.8K ﹤0.01% 5694
2023
Q3
Sell
-2,502
Closed -$4.3K 8593
2023
Q2
$4K Buy
2,502
+1,326
+113% +$2.4K ﹤0.01% 8000
2023
Q1
$1K Buy
+1,176
New +$1.02K ﹤0.01% 8633
2022
Q3
Sell
-14,531
Closed -$16.4K 9839
2022
Q2
$9K Buy
14,531
+1,146
+9% +$1.52K ﹤0.01% 8348
2022
Q1
$34K Sell
13,385
-74,868
-85% -$219K ﹤0.01% 7622
2021
Q4
$343K Buy
+88,253
New +$443K ﹤0.01% 4359
2021
Q2
Sell
-3,703
Closed -$14.8K 9981
2021
Q1
$19K Buy
3,703
+2,366
+177% +$12.6K ﹤0.01% 7480
2020
Q4
$7K Buy
+1,337
New +$8.01K ﹤0.01% 7565
2020
Q3
Sell
-560
Closed -$3.66K 7736
2020
Q2
$2K Sell
560
-498
-47% -$2.29K ﹤0.01% 7221
2020
Q1
$2K Buy
+1,058
New +$4.02K ﹤0.01% 7150

Other funds holding AQST

Simplex Trading's AQST Position: Q4 2025 in Review

Simplex Trading sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 51,177 shares — an estimated $319K sold.

Simplex Trading first reported a position in AQST in Q1 2020 and held it in 13 quarters. The position peaked at $343K in Q4 2021. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • Simplex Trading reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 51,177 Aquestive Therapeutics shares in Q4 2025, an estimated $319K.
  • Simplex Trading first reported a position in Aquestive Therapeutics in Q1 2020 and held it in 13 quarters.
  • Simplex Trading's Aquestive Therapeutics position peaked at $343K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.